FABP4 and cancer: In the present study, we demonstrated that elevated circulating FABP4 concentration predicts cardiovascular death, but not all-cause death or cancer death, as a hard endpoint after adjustment of confounding factors including hsCRP in a general population (Table 3, Model 3 and Model 4).